Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: Attributes, cancer worry, and barriers to testing in a multicenter clinical cohort

C Foster, D G R Evans, R Eeles, D Eccles, S Ashley, L Brooks, T Cole, J Cook, R Davidson, H Gregory, J Mackay, P J Morrison, M Watson

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

BRCA1/2 test decliners/deferrers have received almost no attention in the literature and this is the first study of this population in the United Kingdom. The aim of this multicenter study is to examine the attributes of a group of individuals offered predictive genetic testing for breast/ovarian cancer predisposition who did not wish to proceed with testing at the time of entry into this study. This forms part of a larger study involving 9 U.K. centers investigating the psychosocial impact of predictive genetic testing for BRCA1/2. Cancer worry and reasons for declining or deferring BRCA1/2 predictive genetic testing were evaluated by questionnaire following genetic counseling. A total of 34 individuals declined the offer of predictive genetic testing. Compared to the national cohort of test acceptors, test decliners are significantly younger. Female test decliners have lower levels of cancer worry than female test acceptors. Barriers to testing include apprehension about the result, traveling to the genetics clinic, and taking time away from work/family. Women are more likely than men to worry about receiving less screening if found not to be a carrier. The findings do not indicate that healthy BRCA1/2 test decliners are a more vulnerable group in terms of cancer worry. However, barriers to testing need to be discussed in genetic counseling.

Original languageEnglish
Pages (from-to)23-29
Number of pages7
JournalGenetic Testing
Volume8
Issue number1
DOIs
Publication statusPublished - 2004

Keywords

  • breast-cancer
  • risk perception
  • women
  • families

Cite this

Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers : Attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. / Foster, C ; Evans, D G R ; Eeles, R ; Eccles, D ; Ashley, S ; Brooks, L ; Cole, T ; Cook, J ; Davidson, R ; Gregory, H ; Mackay, J ; Morrison, P J ; Watson, M .

In: Genetic Testing, Vol. 8, No. 1, 2004, p. 23-29.

Research output: Contribution to journalArticle

Foster, C, Evans, DGR, Eeles, R, Eccles, D, Ashley, S, Brooks, L, Cole, T, Cook, J, Davidson, R, Gregory, H, Mackay, J, Morrison, PJ & Watson, M 2004, 'Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: Attributes, cancer worry, and barriers to testing in a multicenter clinical cohort' Genetic Testing, vol. 8, no. 1, pp. 23-29. https://doi.org/10.1089/109065704323016003
Foster, C ; Evans, D G R ; Eeles, R ; Eccles, D ; Ashley, S ; Brooks, L ; Cole, T ; Cook, J ; Davidson, R ; Gregory, H ; Mackay, J ; Morrison, P J ; Watson, M . / Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers : Attributes, cancer worry, and barriers to testing in a multicenter clinical cohort. In: Genetic Testing. 2004 ; Vol. 8, No. 1. pp. 23-29.
@article{7b8ed7e434f345f4aa9c324c462ddeaa,
title = "Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers: Attributes, cancer worry, and barriers to testing in a multicenter clinical cohort",
abstract = "BRCA1/2 test decliners/deferrers have received almost no attention in the literature and this is the first study of this population in the United Kingdom. The aim of this multicenter study is to examine the attributes of a group of individuals offered predictive genetic testing for breast/ovarian cancer predisposition who did not wish to proceed with testing at the time of entry into this study. This forms part of a larger study involving 9 U.K. centers investigating the psychosocial impact of predictive genetic testing for BRCA1/2. Cancer worry and reasons for declining or deferring BRCA1/2 predictive genetic testing were evaluated by questionnaire following genetic counseling. A total of 34 individuals declined the offer of predictive genetic testing. Compared to the national cohort of test acceptors, test decliners are significantly younger. Female test decliners have lower levels of cancer worry than female test acceptors. Barriers to testing include apprehension about the result, traveling to the genetics clinic, and taking time away from work/family. Women are more likely than men to worry about receiving less screening if found not to be a carrier. The findings do not indicate that healthy BRCA1/2 test decliners are a more vulnerable group in terms of cancer worry. However, barriers to testing need to be discussed in genetic counseling.",
keywords = "breast-cancer, risk perception, women, families",
author = "C Foster and Evans, {D G R} and R Eeles and D Eccles and S Ashley and L Brooks and T Cole and J Cook and R Davidson and H Gregory and J Mackay and Morrison, {P J} and M Watson",
year = "2004",
doi = "10.1089/109065704323016003",
language = "English",
volume = "8",
pages = "23--29",
journal = "Genetic Testing",
issn = "1090-6576",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Non-uptake of predictive genetic testing for BRCA1/2 among relatives of known carriers

T2 - Attributes, cancer worry, and barriers to testing in a multicenter clinical cohort

AU - Foster, C

AU - Evans, D G R

AU - Eeles, R

AU - Eccles, D

AU - Ashley, S

AU - Brooks, L

AU - Cole, T

AU - Cook, J

AU - Davidson, R

AU - Gregory, H

AU - Mackay, J

AU - Morrison, P J

AU - Watson, M

PY - 2004

Y1 - 2004

N2 - BRCA1/2 test decliners/deferrers have received almost no attention in the literature and this is the first study of this population in the United Kingdom. The aim of this multicenter study is to examine the attributes of a group of individuals offered predictive genetic testing for breast/ovarian cancer predisposition who did not wish to proceed with testing at the time of entry into this study. This forms part of a larger study involving 9 U.K. centers investigating the psychosocial impact of predictive genetic testing for BRCA1/2. Cancer worry and reasons for declining or deferring BRCA1/2 predictive genetic testing were evaluated by questionnaire following genetic counseling. A total of 34 individuals declined the offer of predictive genetic testing. Compared to the national cohort of test acceptors, test decliners are significantly younger. Female test decliners have lower levels of cancer worry than female test acceptors. Barriers to testing include apprehension about the result, traveling to the genetics clinic, and taking time away from work/family. Women are more likely than men to worry about receiving less screening if found not to be a carrier. The findings do not indicate that healthy BRCA1/2 test decliners are a more vulnerable group in terms of cancer worry. However, barriers to testing need to be discussed in genetic counseling.

AB - BRCA1/2 test decliners/deferrers have received almost no attention in the literature and this is the first study of this population in the United Kingdom. The aim of this multicenter study is to examine the attributes of a group of individuals offered predictive genetic testing for breast/ovarian cancer predisposition who did not wish to proceed with testing at the time of entry into this study. This forms part of a larger study involving 9 U.K. centers investigating the psychosocial impact of predictive genetic testing for BRCA1/2. Cancer worry and reasons for declining or deferring BRCA1/2 predictive genetic testing were evaluated by questionnaire following genetic counseling. A total of 34 individuals declined the offer of predictive genetic testing. Compared to the national cohort of test acceptors, test decliners are significantly younger. Female test decliners have lower levels of cancer worry than female test acceptors. Barriers to testing include apprehension about the result, traveling to the genetics clinic, and taking time away from work/family. Women are more likely than men to worry about receiving less screening if found not to be a carrier. The findings do not indicate that healthy BRCA1/2 test decliners are a more vulnerable group in terms of cancer worry. However, barriers to testing need to be discussed in genetic counseling.

KW - breast-cancer

KW - risk perception

KW - women

KW - families

U2 - 10.1089/109065704323016003

DO - 10.1089/109065704323016003

M3 - Article

VL - 8

SP - 23

EP - 29

JO - Genetic Testing

JF - Genetic Testing

SN - 1090-6576

IS - 1

ER -